(Q34162729)

31 July 2017

Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias (English)

1 reference

31 July 2017

1 reference

9

Hagop Kantarjian

1 reference

31 July 2017

11

Srdan Verstovsek

1 reference

31 July 2017

Omar Abdel-Wahab

1

1 reference

ORCID Public Data File 2021

Cyrus V Hedvat

object named as

Cyrus Hedvat

6

1 reference

ORCID Public Data File 2021

Carlos B Bueso-Ramos

8

object named as

Carlos Bueso-Ramos

1 reference

31 July 2017

10

Ross L Levine

1 reference

31 July 2017

2

Taghi Manshouri

1 reference

31 July 2017

7

Adriana Heguy

1 reference

31 July 2017

Jay Patel

3

1 reference

31 July 2017

Kelly Harris

4

1 reference

31 July 2017

Jinjuan Yao

5

1 reference

31 July 2017

language of work or name

English

0 references

publication date

12 January 2010

1 reference

31 July 2017

1 reference

31 July 2017

70

1 reference

31 July 2017

2

1 reference

31 July 2017

447-452

1 reference

Genomic and biological characterization of exon 4 KRAS mutations in human cancer

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2947340

Recurring mutations found by sequencing an acute myeloid leukemia genome

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2947340

Mutation in TET2 in myeloid cancers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2947340

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2947340

IDH1 and IDH2 mutations in gliomas

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2947340

The myeloproliferative disorders

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2947340

X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2947340

A gain-of-function mutation of JAK2 in myeloproliferative disorders

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2947340

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2947340

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2947340

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2947340

The very long-term evolution of polycythemia vera: an analysis of 318 patients initially treated by phlebotomy or 32P between 1969 and 1981.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2947340

Mutations of ASXL1 gene in myeloproliferative neoplasms.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2947340

Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2947340

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2947340

Molecular mechanisms of tumor progression in chronic myeloproliferative disorders

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20068184

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20068184

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20068184

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/0008-5472.CAN-09-3783

1 reference

31 July 2017

1 reference

31 July 2017

1 reference